1998
DOI: 10.1289/ehp.98106505
|View full text |Cite
|
Sign up to set email alerts
|

Neurotoxicity testing: a discussion of in vitro alternatives.

Abstract: A large number of chemicals may exert adverse effects on the central and/or peripheral nervous system. A commonly recommended strategy for neurotoxicity testing is that of a tiered approach aimed at identifying and characterizing the neurotoxicity of a compound. Guidelines exist in the United States and other countries that define the tests to be utilized in tier 1 testing. To address problems related to the increasing cost and time required for toxicity testing, the increasing number of chemicals being develo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
41
0

Year Published

2007
2007
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 53 publications
(41 citation statements)
references
References 13 publications
0
41
0
Order By: Relevance
“…Such a battery should be seen as a Tier I approach, to be followed, in case of positive indications of neurotoxicity (as in the present case), by a series of Tier II tests in vitro exploring additional end-points of neurotoxicity (Costa, 1998;Harry et al, 1998;Stacey and Viviani, 2001;Gartlon et al, 2006). A very important step in this process would obviously be that of validation, which could initially be accomplished by testing a number of known neurotoxic and non-neurotoxic compounds to ensure specificity and rate of false positives and negatives.…”
Section: Mehgmentioning
confidence: 99%
See 2 more Smart Citations
“…Such a battery should be seen as a Tier I approach, to be followed, in case of positive indications of neurotoxicity (as in the present case), by a series of Tier II tests in vitro exploring additional end-points of neurotoxicity (Costa, 1998;Harry et al, 1998;Stacey and Viviani, 2001;Gartlon et al, 2006). A very important step in this process would obviously be that of validation, which could initially be accomplished by testing a number of known neurotoxic and non-neurotoxic compounds to ensure specificity and rate of false positives and negatives.…”
Section: Mehgmentioning
confidence: 99%
“…Guidelines for neurotoxicity and developmental neurotoxicity testing have been developed, that require cumbersome protocols prescribed for standard tests in animals. Economical and time considerations, as well as ethical considerations for reducing the number of animals, have in recent years argued for the need to develop alternative in vitro methodologies to test for potential neurotoxicity (Costa, 1998;Harry et al, 1998;Gartlon et al, 2006). No in vitro neurotoxicity test has been fully validated so far, and regulatory agencies accept only in vivo animal data to predict potential neurotoxic effects in humans.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…One strategy proposed to resolve this problem is the use of screening techniques based on cell culture systems or lower organisms as the first stage of evaluation, thus enabling subsequent animal studies to focus on those compounds most likely to cause developmental neurotoxicity (Costa 1998; Slotkin 2004b). This approach was recently endorsed in a report from the Inspector General of the U.S. EPA (U.S.…”
mentioning
confidence: 99%
“…A new set of test paradigms, relying on primary work in cell culture, invertebrates, or non-mammalian models, followed by more targeted examinations of specific processes in mammalian models, may unite cutting-edge academic research with the need for establishing flexible guidelines for developmental neurotoxicity [9,10]. This approach was recently endorsed in a report from the Inspector General of the U.S. EPA [5] as well as by outside groups [1,[9][10][11]. In this paper, we summarize techniques used in each stage respectively, as follows.…”
Section: Introductionmentioning
confidence: 99%